Long-Term Use of Certain Contraception Injections Associated With Increased Fracture Risk
Key points
- A new study presented May 6 at the World Congress on Osteoporosis (IOF WCO-ECCEO10) in Florence, Italy shows that DMPA, a commonly used injectible contraceptive, is associated with higher risk of bone fracture when used alone, and not in combination with estrogens.
- Depot medroxyprogesterone acetate (DMPA) is a progestin-only long acting reversible hormonal contraceptive birth control drug which is injected every 3 months.
- Previous studies have shown that use of DMPA is associated with impaired bone acquisition during adolescence and accelerated bone loss later in life, mainly in younger women with lower estrogen levels.
- The study, conducted by researchers at the University Hospital Basel, Switzerland and the Boston University Medical Center, Lexington, USA, used a case-control analysis to evaluate the relationship between long-term use of DMPA, with or without estrogen, and the risk of fractures.
A new study presented May 6 at the World Congress on Osteoporosis (IOF WCO-ECCEO10) in Florence, Italy shows that DMPA, a commonly used injectible contraceptive, is associated with higher risk of bone fracture when used alone, and not in combination with estrogens.
Depot medroxyprogesterone acetate (DMPA) is a progestin-only long acting reversible hormonal contraceptive birth control drug which is injected every 3 months. It is used by more than 9 million women worldwide, with high usage among teenagers in Europe and the US.
Previous studies have shown that use of DMPA is associated with impaired bone acquisition during adolescence and accelerated bone loss later in life, mainly in younger women with lower estrogen levels. However, few studies have looked into the impact of DMPA on fracture risk.
The study, conducted by researchers at the University Hospital Basel, Switzerland and the Boston University Medical Center, Lexington, USA, used a case-control analysis to evaluate the relationship between long-term use of DMPA, with or without estrogen, and the risk of fractures. The results show that in women below 50 years of age, longer-term use of DMPA of two and more years is associated with a 50% increased risk of fracture. For users of combined estrogen-containing oral contraceptives fracture risk was not increased.
OC7 - published in Osteoporosis International Vol. 21 Sup. 1
--
Story Source: Adapted from materials provided by International Osteoporosis Foundation
International Osteoporosis Foundation (2010, May 6). Long-term use of certain contraception injections associated with increased fracture
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
NewsCDC Report Sheds Light on Contraception Use
Two statistics at the heart of the controversy over mandatory insurance coverage of contraception - that 99% of American women have used contraception, including 98% of Catholics - are getting fresh attention from the…
17 February 2013
NewsContraception: Condoms Are King, Plan B Takes Hold
In the realm of contraception, the condom reigns supreme, but one in 10 have used emergency contraception such as Plan B, according to two reports on the contraceptive methods used by women of reproductive age in the…
17 February 2013
NewsAbusive partners can sabotage contraception
While researchers don't know exactly how common it is, the nation's leading group of obstetricians and gynecologists says women should be screened for 'reproductive coercion.' When a husband hides a wife's birth control…
25 January 2013
